Shared decision-making (SDM) is the process by which patients and clinicians work together to cocreate care plans that respond to the patient’s problematic situation.1 2 In daily life, a familiar ...

We will not keep your email address; we ask for it so your friend knows the email isn't spam.

An evidence-based approach is considered the gold standard for health decision-making. Sometimes, a guideline panel might judge the certainty that the desirable effects of an intervention clearly ...

Objectives We aimed to determine to what extent systematic reviewers and post-preprint and post-publication peer review identified methodological and reporting issues in COVID-19 trials that could be ...

Correspondence to Dr John P A Ioannidis, Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, CA 94305, USA; jioannid{at}stanford.edu Inverse publication ...

Qualitative research has an important place within evidence-based health care (EBHC), contributing to policy on patient safety and quality of care, supporting understanding of the impact of chronic ...

6 Scientific Research Works Peer Support Group (SRWS-PSG), Osaka, Japan Objectives In anticancer clinical trials, particularly open-label trials, central reviewers are recommended to evaluate ...

Correspondence to Dr Paul Fontelo, National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894, USA; fontelo{at}nlm.nih.gov In 1998, the ‘Evidence Cart’ was introduced to provide decision ...

Objectives Drug nomenclature is an international system that helps in identifying the drugs. Trade names often reflect a characteristic of the drug or a relationship that will be of useful value for ...

Objectives To describe the range of collaborative approaches to shared decision-making (SDM) observed in clinical encounters of patients with diabetes and their clinicians. Design A secondary analysis ...

†Composite outcome = all cardiovascular events and all cause mortality. Abbreviations defined in glossary; NNT and CI provided by author. ‡Number needed to treat with an ACE inhibitor based regimen ...